NRT $A7.50 closing today in USD. Back of envelope calculation, NVGN mkt cap 555m USD, MSHL mkt cap 722m USD, NVGN (NRT) owns 90% of MSHL, i.e 648m usd, therefore NVGN (NRT) undervalued by 100m USD... NOT mentioning any other NRT products like NV07, et al.. anyone verify this information?. What would NVGN (NRT price) be if the other 100m USD were factored in.
Possibility of FDA approval for Phenox (monotherapy) ?no side effects, on on Phase II results ?? - is Yale presenting next week ?? with MSHL 30 day quiet period over next week?
Do your own due diligence.
NRT Price at posting:
0.0¢ Sentiment: None Disclosure: Held
